These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9884920)
1. Quality of life effects of alprostadil therapy for erectile dysfunction: results of a trial in Europe and South Africa. Willke RJ; Yen W; Parkerson GR; Linet OI; Erder MH; Glick HA Int J Impot Res; 1998 Dec; 10(4):239-46. PubMed ID: 9884920 [TBL] [Abstract][Full Text] [Related]
2. Quality of life effects of alprostadil therapy for erectile dysfunction. Willke RJ; Glick HA; McCarron TJ; Erder MH; Althof SE; Linet OI J Urol; 1997 Jun; 157(6):2124-8. PubMed ID: 9146597 [TBL] [Abstract][Full Text] [Related]
3. An international comparison of the reliability and responsiveness of the Duke Health Profile for measuring health-related quality of life of patients treated with alprostadil for erectile dysfunction. Parkerson GR; Willke RJ; Hays RD Med Care; 1999 Jan; 37(1):56-67. PubMed ID: 10413393 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. Linet OI; Ogrinc FG N Engl J Med; 1996 Apr; 334(14):873-7. PubMed ID: 8596569 [TBL] [Abstract][Full Text] [Related]
5. Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men. Heaton JP; Lording D; Liu SN; Litonjua AD; Guangwei L; Kim SC; Kim JJ; Zhi-Zhou S; Israr D; Niazi D; Rajatanavin R; Suyono S; Benard F; Casey R; Brock G; Belanger A Int J Impot Res; 2001 Dec; 13(6):317-21. PubMed ID: 11918246 [TBL] [Abstract][Full Text] [Related]
6. Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea. Kim SC; Ahn TY; Choi HK; Choi NG; Chung TG; Chung WS; Hwang TK; Hyun JS; Jung GW; Kim CI; Kim JJ; Kim SW; Lee CH; Lee KS; Lee WH; Min KS; Moon KH; Paic JS; Park KS; Park NC; Park YK; Seo JK; Seo KK; Shin JS; Yoon YR; Lee WC Int J Impot Res; 2000 Apr; 12(2):97-101. PubMed ID: 11052635 [TBL] [Abstract][Full Text] [Related]
7. Intracavernous Alprostadil Alfadex--an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study. Porst H; Buvat J; Meuleman E; Michal V; Wagner G Int J Impot Res; 1998 Dec; 10(4):225-31. PubMed ID: 9884918 [TBL] [Abstract][Full Text] [Related]
8. Long-term, multicenter study of the safety and efficacy of topical alprostadil cream in male patients with erectile dysfunction. Rooney M; Pfister W; Mahoney M; Nelson M; Yeager J; Steidle C J Sex Med; 2009 Feb; 6(2):520-34. PubMed ID: 19138370 [TBL] [Abstract][Full Text] [Related]
9. Sexual rehabilitation and penile pain associated with intracavernous alprostadil after radical prostatectomy. Yiou R; Cunin P; de la Taille A; Salomon L; Binhas M; Lingombet O; Paul M; Abbou C J Sex Med; 2011 Feb; 8(2):575-82. PubMed ID: 20807323 [TBL] [Abstract][Full Text] [Related]
10. Injection anxiety and pain in men using intracavernosal injection therapy after radical pelvic surgery. Nelson CJ; Hsiao W; Balk E; Narus J; Tal R; Bennett NE; Mulhall JP J Sex Med; 2013 Oct; 10(10):2559-65. PubMed ID: 23898886 [TBL] [Abstract][Full Text] [Related]
11. Use of intracavernosal alprostadil in erectile dysfunction. Gingell C Hosp Med; 1998 Oct; 59(10):777. PubMed ID: 9850293 [TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil. Hellstrom WJ; Bennett AH; Gesundheit N; Kaiser FE; Lue TF; Padma-Nathan H; Peterson CA; Tam PY; Todd LK; Varady JC; Place VA Urology; 1996 Dec; 48(6):851-6. PubMed ID: 8973666 [TBL] [Abstract][Full Text] [Related]
13. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy. Engel JD; McVary KT Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction. Kaplan SA; Reis RB; Kohn IJ; Shabsigh R; Te AE Urology; 1998 Nov; 52(5):739-43. PubMed ID: 9801091 [TBL] [Abstract][Full Text] [Related]
15. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)]. Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074 [TBL] [Abstract][Full Text] [Related]
16. A dose-response study of alprostadil sterile powder (S.Po.) (Caverject) for the treatment of erectile dysfunction in Korean and Indonesian men. Choi HK; Adimoelja A; Kim SC; Soebadi DM; Seong DH; Garceau RJ Int J Impot Res; 1997 Mar; 9(1):47-51. PubMed ID: 9138059 [TBL] [Abstract][Full Text] [Related]
17. Short term use of intracavernous vasoactive drugs in the treatment of persistent psychogenic erectile dysfunction. Ghanem H; Sherif T; Adbel-Gawad T; Asaad T Int J Impot Res; 1998 Dec; 10(4):211-4. PubMed ID: 9884916 [TBL] [Abstract][Full Text] [Related]
18. [The opinion of patients treated with intracavernous injections: the EASY survey]. Desvaux P; Alexandre B Presse Med; 2005 Jul; 34(13 Suppl):10-2. PubMed ID: 16158022 [TBL] [Abstract][Full Text] [Related]
19. The use of alprostadil sterile powder in a home self-injection study of Asian men with erectile dysfunction. Wu CC; Xue ZY; Apichat K; Huang ST; He Z; Garceau RJ Clin Ther; 1996; 18(2):256-64. PubMed ID: 8733986 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of alprostadil sterile powder (S. Po., CAVERJECT) in diabetic patients with erectile dysfunction. Tsai YS; Lin JS; Lin YM Eur Urol; 2000 Aug; 38(2):177-83. PubMed ID: 10895010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]